Clin Biochem. 1992 Dec;25(6):415-24. doi: 10.1016/0009-9120(92)90030-v.
This Canadian Society of Clinical Chemists (CSCC) sponsored position statement addresses the problem of nonuniformity of standardization of polypeptide hormone analyses. First we review the structural diversity of selected polypeptide hormones including growth hormone (GH), prolactin, follitropin (FSH), lutropin (LH), human chorionic gonadotropin (hCG), and thyrotropin (TSH) and the problem that this heterogeneity creates. The history and availability of reference materials for the analyses of these hormones are then summarized. Finally we make a list of recommendations regarding standardization, methods of measurement, and reporting of polypeptide hormone results. Implementation of the recommendations will lead to improvement in inter-laboratory comparability and more useful hormone assays.
这份由加拿大临床化学家协会(CSCC)发起的立场声明探讨了多肽激素分析标准化不一致的问题。首先,我们回顾了包括生长激素(GH)、催乳素、促卵泡激素(FSH)、促黄体激素(LH)、人绒毛膜促性腺激素(hCG)和促甲状腺激素(TSH)在内的选定多肽激素的结构多样性,以及这种异质性所带来的问题。然后总结了这些激素分析参考物质的历史和可得性。最后,我们列出了关于多肽激素标准化、测量方法和结果报告的建议清单。实施这些建议将提高实验室间的可比性,并使激素检测更具实用性。